Progyny PGNY
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 18th percentile, 5-year average 54.2x
#2251 of 2994 stocks by PE (1 = cheapest)
Around its usual level · 56th percentile, 5-year average 7.1x
#4641 of 5335 stocks by PB (1 = cheapest)
Around its usual level · 45th percentile, 5-year average 3.3x
#2546 of 5159 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 6.44 | – | 7.13 | 56% (pricier than usual) | #4641 of 5335 (1 = cheapest) |
| PE | 33.19 | 21.08 | 54.19 | 18% (cheaper than usual) | #2251 of 2994 (1 = cheapest) |
| PS | 1.99 | 1.78 | 3.32 | 45% (cheaper than usual) | #2546 of 5159 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on PGNY.
Sign in to join the discussion.